Modern BioPharma Podcast
Un pódcast de Jesse McLaughlin
33 Episodo
-
Season 4 - Andrew Lamore - ASME BPE
Publicado: 28/2/2023 -
Sumit Verma of Iovance Biotherapeutics - 1 Time Therapy for Solid Tumors
Publicado: 1/12/2022 -
Rapid Microbiological Testing with Peggy Banarhall and Tracy Radcliffe of Mettler Toledo
Publicado: 19/7/2022 -
Jake Adams - CRB - The Future of ATMPs
Publicado: 10/3/2022 -
Jon Browne - Qualification & Commissioning in Pharma
Publicado: 1/3/2022 -
AI-ML in Pharma Manufacturing - Vijay Yadav - Merck
Publicado: 22/2/2022 -
Blockchain in Pharma - Tanya Sharma and Najib Rehman
Publicado: 16/12/2021 -
The Pharma Job Market - An Interview Mashup
Publicado: 17/11/2021 -
Women in Pharma - An Interview with Jennifer Lauria Clark
Publicado: 3/11/2021 -
MBP - Ravi Samavedam - Cleanrooms on Demand
Publicado: 15/9/2021 -
Integrated Project Delivery - Josh Miksch - CRB ONEsolution
Publicado: 4/8/2021 -
Predicting Diaphragm Valve Failure - Milena McFeeters
Publicado: 28/7/2021 -
Maintenance 4.0 - Tobias Kuners of Koenders - Season 2
Publicado: 22/7/2021 -
Emergency Use Authorizations - MMS Holdings Interview - MBP Season 2
Publicado: 8/6/2021 -
MBP - Ross Youngs - Biosortia - The Future of Drug Discovery
Publicado: 28/9/2020 -
MBP - Gil Roth - Pharma and Biopharma Outsourcing Association
Publicado: 21/9/2020 -
MBP - Jesse Coiro - Erlab
Publicado: 17/8/2020 -
MBP - Jarrod Wrampe - CRB
Publicado: 20/7/2020 -
MBP - Kevin Chronley - A/Z Corp
Publicado: 6/7/2020 -
MBP - Brian Hagopian - Clear Water Consulting - Part 3 Rapid Microbiological Monitoring
Publicado: 24/6/2020
The Modern BioPharma Podcast was born out of the 2020 COVID-19 Pandemic and the desire to connect professionals in the pharmaceutical engineering community to the stories of others around them and what they are doing to make a difference. This industry is one of resistance to change all while life altering medicines and therapies are coming into existence that demand a different kind of manufacturing plant. The same people work on these facilities across the industry. Let's get to know each other.